Latest filing published 17 Jun 2026 for Medline Inc..
Insider track record
No signal scores available.
James M. Boyle: trading record in brief
James M. Boyle discloses dealings in Medline Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 16 December 2025 to 15 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 June 2026, the filings show a share grant in Medline Inc. Filings reach the SEC (Form 4) feed a median of 41 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James M. Boyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,370 sharesClass A Common StockSEC:0001193125-26-274286:0
- 514,876 sharesClass B Common StockSEC:0001193125-26-096654:1
- 31,739 shares0Class A Common StockSEC:0001193125-26-096654:2
- 24,313 sharesClass B Common StockSEC:0001193125-26-096654:0
4 of 4 declarations
